PCRX Pacira BioSciences, Inc.
$36.48 —
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
—
YTD
—
P/E
99.92
P/B
1.61
ROE
2.1%
Div yield
—
Beta
—
Market cap
$1.5B
RSI (14)
83
Next earnings
Feb 24, 2027
Same sector · Health Care
Compare PCRX with NVO and JNJ →Follow PCRX in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 18, 2026 · EOD, no live order bookOpen
$36.48
Close
$36.48
Day high
$36.48
Day low
$36.48
Volume
0
Latest headlines
Viatris Completes Acquisition of Pacira BioSciences
Yahoo Finance · Nov 17
Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.
Yahoo Finance · Oct 30
Pacira BioSciences (PCRX) Reports Next Week: Wall Street Expects Earnings Growth
Yahoo Finance · Oct 29
Pacira BioSciences (PCRX) Stock Gets Fair Value Boost After Viatris Deal Framing
Yahoo Finance · Oct 23
Pacira Biosciences' Acquisition by Viatris Unlikely to See Superior Bid, RBC Says
Yahoo Finance · Oct 9
Viatris (VTRS) Buys Pacira As Fair Value Stays In Focus
Yahoo Finance · Oct 9
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Nov 17, 2026 View → 8-K Nov 12, 2026 View → 10-Q Nov 5, 2026 View → 8-K Nov 5, 2026 View → 8-K Oct 8, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell PCRX. Try it in the Lab to size a position and see the risk.